MTBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.406600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.299000E-01
Normal-vs-Stage2
8.913400E-01
Normal-vs-Stage3
2.026800E-01
Normal-vs-Stage4
7.921400E-01
Stage1-vs-Stage2
8.023600E-01
Stage1-vs-Stage3
9.122300E-02
Stage1-vs-Stage4
9.401400E-01
Stage2-vs-Stage3
1.612770E-01
Stage2-vs-Stage4
7.794000E-01
Stage3-vs-Stage4
3.511400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.997200E-01
Normal-vs-AfricanAmerican
4.643000E-01
Normal-vs-Asian
4.127200E-01
Caucasian-vs-AfricanAmerican
3.784200E-01
Caucasian-vs-Asian
2.417800E-01
AfricanAmerican-vs-Asian
9.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.157800E-01
Normal-vs-Female
8.802600E-01
Male-vs-Female
8.437400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.776400E-01
Normal-vs-Age(41-60Yrs)
9.437200E-01
Normal-vs-Age(61-80Yrs)
7.754400E-01
Normal-vs-Age(81-100Yrs)
8.994400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.593000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.032000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.422400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.868200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.795600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.514000E-01
Normal-vs-Daily Drinker
8.979400E-01
Normal-vs-Weekly Drinker
8.957800E-01
Normal-vs-Occasional Drinker
7.975400E-01
Normal-vs-Social Drinker
7.954800E-01
Non Drinker-vs-Daily Drinker
8.703000E-01
Non Drinker-vs-Weekly Drinker
9.631200E-01
Non Drinker-vs-Occasional Drinker
3.671800E-01
Non Drinker-vs-Social Drinker
9.578400E-01
Daily Drinker-vs-Weekly Drinker
9.358200E-01
Daily Drinker-vs-Occasional Drinker
4.431400E-01
Daily Drinker-vs-Social Drinker
8.312600E-01
Weekly Drinker-vs-Occasional Drinker
5.106000E-01
Weekly Drinker-vs-Social Drinker
9.317800E-01
Occasional Drinker-vs-Social Drinker
3.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.673000E-01
Normal-vs-Grade 2
7.183000E-01
Normal-vs-Grade 3
8.298400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.096030E-01
Grade 1-vs-Grade 3
9.987200E-04
Grade 1-vs-Grade 4
6.673000E-01
Grade 2-vs-Grade 3
1.020040E-02
Grade 2-vs-Grade 4
7.183000E-01
Grade 3-vs-Grade 4
8.298400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.742800E-01
Normal-vs-NonDiabetic
8.120800E-01
Diabetic-vs-NonDiabetic
7.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.798200E-01
Normal-vs-NoPancreatitis
8.258400E-01
Pancreatitis-vs-NoPancreatitis
6.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.748600E-01
Normal-vs-N1
8.971600E-01
N0-vs-N1
6.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.808800E-01
Normal-vs-TP53-NonMutant
5.961600E-01
TP53-Mutant-vs-TP53-NonMutant
1.82380000002258E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
